{"data":[{"accessionNo":"0001104659-26-115112","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":4260038,"percentOfClass":7,"filedAt":"2026-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-115112","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4260038,"percentOfClass":7,"filedAt":"2026-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-115112","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":4260038,"percentOfClass":7,"filedAt":"2026-10-09","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-098866","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-08-17","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3376401,"percentOfClass":5.6,"filedAt":"2026-08-19","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-098866","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-08-17","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":3376401,"percentOfClass":5.6,"filedAt":"2026-08-19","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-098866","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-08-17","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":3376401,"percentOfClass":5.6,"filedAt":"2026-08-19","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001167557-26-000170","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"AQR Capital Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":3497695,"percentOfClass":5.82,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001167557-26-000170","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock, par value $0.001 per share","eventDate":"2026-06-30","reportingPerson":"AQR Capital Management Holdings, LLC","reportingCik":null,"personType":"HC","sharesOwned":3497695,"percentOfClass":5.82,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0000093751-26-000309","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001347178","issuerName":"VANDA PHARMACEUTICALS INC","ticker":"VNDA","cusip":"921659108","securityClass":"COMMON STOCK","eventDate":"2026-03-31","reportingPerson":"STATE STREET CORPORATION","reportingCik":null,"personType":"HC","sharesOwned":3015562,"percentOfClass":5.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0002052113-26-000465","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"BlackRock Portfolio Management LLC","reportingCik":null,"personType":"HC","sharesOwned":2508488,"percentOfClass":4.2,"filedAt":"2026-04-29","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0000102909-26-002588","formType":"SCHEDULE 13G/A","amendmentNo":7,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc","ticker":"VNDA","cusip":"921659108","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-27","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0002052113-26-000212","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"BlackRock Portfolio Management LLC","reportingCik":null,"personType":"HC","sharesOwned":3251563,"percentOfClass":5.5,"filedAt":"2026-01-21","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-002483","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1679013,"percentOfClass":2.8,"filedAt":"2026-01-09","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-002483","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":1679013,"percentOfClass":2.8,"filedAt":"2026-01-09","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"},{"accessionNo":"0001104659-26-002483","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001347178","issuerName":"Vanda Pharmaceuticals Inc.","ticker":"VNDA","cusip":null,"securityClass":"Common Stock, par value $0.001 per share","eventDate":"2025-12-31","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":1679013,"percentOfClass":2.8,"filedAt":"2026-01-09","canonicalUrl":"https://xoomar.com/markets/stocks/vnda"}],"updatedAt":"2026-10-24T17:02:16.248Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/vnda","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}